GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CUC 9158.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

611

-0.16%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥54.35bn

FY2021FY2026

Net income

¥2.85bn

FY2021FY2026

Free cash flow

−¥912.0m

FY2021FY2026

Shareholders' equity

¥33.25bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue¥54.35bn¥47.04bn¥33.02bn¥35.21bn¥35.31bn¥16.61bn
Gross profit¥25.41bn¥19.90bn¥14.12bn¥12.55bn¥13.18bn¥6.75bn
Operating income¥3.62bn¥4.79bn¥3.72bn¥3.71bn¥5.46bn¥1.84bn
Net income¥2.85bn¥3.13bn¥2.60bn¥2.42bn¥2.71bn¥1.10bn
Diluted earnings per share97.36106.8088.5582.6593.2537.89

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets¥98.05bn¥85.17bn¥62.84bn¥39.75bn¥34.53bn¥28.45bn
Cash and short-term investments¥15.84bn¥7.53bn¥8.26bn¥4.12bn¥4.36bn¥3.62bn
Total liabilities¥64.16bn¥54.88bn¥34.83bn¥27.83bn¥24.85bn¥23.11bn
Debt¥52.53bn¥43.54bn¥26.72bn¥21.45bn¥14.90bn¥18.77bn
Shareholders' equity¥33.25bn¥29.68bn¥27.32bn¥11.70bn¥9.46bn¥4.73bn
Shares outstanding29m29m29m29m29m29m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations¥5.71bn¥2.50bn¥4.16bn¥2.36bn¥6.62bn¥2.12bn
Capital spending−¥6.62bn−¥5.55bn−¥4.86bn−¥5.45bn−¥831.0m−¥389.0m
Free cash flow−¥912.0m−¥3.04bn−¥703.0m−¥3.10bn¥5.79bn¥1.73bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥14.16bn¥14.18bn¥13.88bn¥13.29bn¥13.00bn¥12.48bn¥12.95bn¥11.01bn
Gross profit¥6.22bn¥6.80bn¥6.53bn¥6.18bn¥5.91bn¥4.86bn¥5.51bn¥5.04bn
Operating income−¥146.0m¥1.07bn¥1.16bn¥787.0m¥600.0m¥361.0m¥1.43bn¥1.64bn
Net income−¥282.0m¥1.42bn¥820.0m¥404.0m¥208.0m¥361.0m¥761.0m¥1.04bn
Diluted earnings per share-9.6248.5127.9713.787.1012.3125.9635.58
Total assets¥101.14bn¥98.05bn¥95.98bn¥94.14bn¥86.17bn¥85.17bn¥86.78bn¥70.22bn
Cash and short-term investments¥18.33bn¥15.84bn¥13.27bn¥13.32bn¥7.04bn¥7.53bn¥11.57bn¥13.16bn
Debt¥7.66bn¥35.41bn¥6.39bn¥34.60bn¥8.11bn¥26.23bn¥5.50bn¥25.36bn
Shareholders' equity¥33.43bn¥33.25bn¥31.59bn¥30.16bn¥29.54bn¥29.68bn¥29.90bn¥27.93bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.6%26.8%—
Operating income-0.8%14.5%—
Net income5.6%21.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin44.7%42.4%41.5%—
Operating margin8.3%9.3%10.4%—
Net margin5.9%6.5%6.7%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023
Price to earnings7.07.919.627.0
Price to sales0.40.51.51.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.